Protalix Ptb Ratio vs Interest Coverage Analysis

PLX Stock  USD 2.38  0.03  1.28%   
Protalix Biotherapeutics financial indicator trend analysis is much more than just breaking down Protalix Biotherapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protalix Biotherapeutics is a good investment. Please check the relationship between Protalix Biotherapeutics Ptb Ratio and its Interest Coverage accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protalix Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Protalix Stock please use our How to Invest in Protalix Biotherapeutics guide.

Ptb Ratio vs Interest Coverage

Ptb Ratio vs Interest Coverage Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Protalix Biotherapeutics Ptb Ratio account and Interest Coverage. At this time, the significance of the direction appears to have no relationship.
The correlation between Protalix Biotherapeutics' Ptb Ratio and Interest Coverage is 0.04. Overlapping area represents the amount of variation of Ptb Ratio that can explain the historical movement of Interest Coverage in the same time period over historical financial statements of Protalix Biotherapeutics, assuming nothing else is changed. The correlation between historical values of Protalix Biotherapeutics' Ptb Ratio and Interest Coverage is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ptb Ratio of Protalix Biotherapeutics are associated (or correlated) with its Interest Coverage. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Coverage has no effect on the direction of Ptb Ratio i.e., Protalix Biotherapeutics' Ptb Ratio and Interest Coverage go up and down completely randomly.

Correlation Coefficient

0.04
Relationship DirectionPositive 
Relationship StrengthInsignificant

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Interest Coverage

Most indicators from Protalix Biotherapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protalix Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protalix Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Protalix Stock please use our How to Invest in Protalix Biotherapeutics guide.At this time, Protalix Biotherapeutics' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 24.9 M in 2025, despite the fact that Discontinued Operations is likely to grow to (206.5 K).
 2022 2023 2024 2025 (projected)
Total Revenue47.6M65.5M75.3M79.1M
Depreciation And Amortization1.1M1.2M1.4M1.7M

Protalix Biotherapeutics fundamental ratios Correlations

0.10.22-0.230.770.610.930.10.130.32-0.660.520.990.470.150.48-0.28-0.190.410.430.490.540.070.10.230.15
0.10.490.15-0.250.37-0.10.560.57-0.35-0.28-0.090.04-0.10.240.36-0.410.07-0.460.370.29-0.360.10.55-0.37-0.17
0.220.490.53-0.140.220.090.140.47-0.48-0.490.090.210.220.130.16-0.57-0.22-0.140.430.64-0.080.120.48-0.35-0.39
-0.230.150.53-0.38-0.35-0.290.120.13-0.19-0.340.13-0.18-0.04-0.33-0.44-0.45-0.31-0.30.290.16-0.31-0.10.14-0.08-0.57
0.77-0.25-0.14-0.380.290.93-0.35-0.320.63-0.370.630.790.67-0.090.290.16-0.10.70.070.340.65-0.04-0.290.560.36
0.610.370.22-0.350.290.420.480.170.2-0.320.370.470.470.00.96-0.30.410.120.260.260.220.630.090.080.5
0.93-0.10.09-0.290.930.42-0.2-0.090.44-0.510.560.950.60.080.35-0.01-0.190.590.250.510.63-0.05-0.10.320.21
0.10.560.140.12-0.350.48-0.20.56-0.1-0.34-0.030.01-0.180.070.38-0.640.27-0.20.47-0.2-0.010.460.33-0.130.0
0.130.570.470.13-0.320.17-0.090.56-0.62-0.42-0.420.12-0.40.680.1-0.62-0.27-0.370.740.05-0.15-0.070.76-0.6-0.52
0.32-0.35-0.48-0.190.630.20.44-0.1-0.62-0.160.830.320.55-0.710.210.130.140.57-0.13-0.110.460.2-0.570.80.7
-0.66-0.28-0.49-0.34-0.37-0.32-0.51-0.34-0.42-0.16-0.49-0.67-0.290.01-0.180.770.51-0.12-0.71-0.29-0.250.0-0.31-0.270.23
0.52-0.090.090.130.630.370.56-0.03-0.420.83-0.490.50.76-0.730.34-0.220.020.560.120.290.470.31-0.340.690.55
0.990.040.21-0.180.790.470.950.010.120.32-0.670.50.430.170.34-0.25-0.30.430.430.490.56-0.040.10.240.06
0.47-0.10.22-0.040.670.470.6-0.18-0.40.55-0.290.760.43-0.440.530.010.240.640.050.360.510.39-0.40.490.48
0.150.240.13-0.33-0.090.00.080.070.68-0.710.01-0.730.17-0.44-0.010.0-0.2-0.280.290.07-0.11-0.320.53-0.65-0.53
0.480.360.16-0.440.290.960.350.380.10.21-0.180.340.340.53-0.01-0.170.510.120.170.230.170.650.030.070.58
-0.28-0.41-0.57-0.450.16-0.3-0.01-0.64-0.620.130.77-0.22-0.250.010.0-0.170.260.1-0.76-0.04-0.05-0.3-0.57-0.010.26
-0.190.07-0.22-0.31-0.10.41-0.190.27-0.270.140.510.02-0.30.24-0.20.510.260.12-0.35-0.070.060.76-0.210.060.52
0.41-0.46-0.14-0.30.70.120.59-0.2-0.370.57-0.120.560.430.64-0.280.120.10.12-0.010.060.950.17-0.460.520.48
0.430.370.430.290.070.260.250.470.74-0.13-0.710.120.430.050.290.17-0.76-0.35-0.01-0.020.16-0.010.56-0.14-0.36
0.490.290.640.160.340.260.51-0.20.05-0.11-0.290.290.490.360.070.23-0.04-0.070.06-0.020.070.030.09-0.21-0.07
0.54-0.36-0.08-0.310.650.220.63-0.01-0.150.46-0.250.470.560.51-0.110.17-0.050.060.950.160.070.16-0.330.40.38
0.070.10.12-0.1-0.040.63-0.050.46-0.070.20.00.31-0.040.39-0.320.65-0.30.760.17-0.010.030.160.050.220.5
0.10.550.480.14-0.290.09-0.10.330.76-0.57-0.31-0.340.1-0.40.530.03-0.57-0.21-0.460.560.09-0.330.05-0.41-0.47
0.23-0.37-0.35-0.080.560.080.32-0.13-0.60.8-0.270.690.240.49-0.650.07-0.010.060.52-0.14-0.210.40.22-0.410.45
0.15-0.17-0.39-0.570.360.50.210.0-0.520.70.230.550.060.48-0.530.580.260.520.48-0.36-0.070.380.5-0.470.45
Click cells to compare fundamentals

Protalix Biotherapeutics Account Relationship Matchups

Protalix Biotherapeutics fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets67.9M73.7M55.8M84.4M97.1M51.0M
Other Current Liab13.9M15.2M10.6M15.3M17.6M18.4M
Total Current Liabilities86.5M33.2M32.4M45.5M52.4M55.0M
Net Debt46.1M(5.5M)16.4M2.6M3.0M3.2M
Cash18.3M39.0M17.1M23.6M27.2M31.8M
Non Current Assets Total12.2M12.0M10.9M14.5M16.7M9.6M
Cash And Short Term Investments38.5M39.0M22.2M44.6M51.2M33.7M
Net Receivables2M3.4M4.6M5.3M6.1M3.1M
Common Stock Shares Outstanding29.1M44.1M48.5M82.4M94.8M99.5M
Liabilities And Stockholders Equity67.9M73.7M55.8M84.4M97.1M51.0M
Non Current Liabilities Total8.5M46.5M34.0M5.3M6.1M5.8M
Other Current Assets2.1M1.3M1.3M1.1M949.5K1.6M
Total Liab95.0M79.7M66.4M50.9M58.5M56.1M
Total Current Assets55.7M61.7M44.9M69.9M80.4M42.5M
Short Long Term Debt Total64.4M33.5M33.5M26.3M30.2M51.9M
Total Stockholder Equity(27.0M)(6.0M)(10.6M)33.6M30.2M31.7M
Property Plant And Equipment Net10.4M9.9M9.6M10.9M12.5M10.5M
Retained Earnings(347.4M)(374.9M)(389.9M)(381.5M)(343.4M)(326.2M)
Non Currrent Assets Other1.8M2.1M1.3M528K607.2K576.8K
Other Stockholder Equity320.3M368.9M379.2M415.0M477.3M501.2M
Short Term Debt59.9M2.4M2.2M23.1M26.5M18.6M
Common Stock35K46K54K73K84.0K62.8K
Accounts Payable7.2M7.0M5.9M4.3M5.0M4.3M
Short Term Investments20.3M39.0M5.1M20.9M24.1M25.3M
Other Assets7.4K2.1M1.3M1.01.151.09
Other Liab20.1M4.0M14.3M1.6M1.5M1.4M
Property Plant Equipment5.3M10.4M9.9M9.6M8.7M8.1M
Current Deferred Revenue5.4M8.6M13.2M2.9M3.3M3.1M
Inventory13.1M18.0M16.8M19.0M21.9M23.0M
Net Tangible Assets(70.3M)(27.0M)(6.0M)(10.6M)(9.6M)(10.1M)
Long Term Debt51.0M51K27.9M28.2M25.4M28.8M
Capital Surpluse270.5M320.3M368.9M379.2M436.0M272.0M
Property Plant And Equipment Gross10.4M9.9M9.6M45.6M52.4M55.0M
Long Term Debt Total51.5M51K27.9M28.2M25.4M28.3M
Net Invested Capital31.5M21.9M17.5M53.8M61.9M65.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protalix Stock Analysis

When running Protalix Biotherapeutics' price analysis, check to measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.